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A series of 1-glycosylmethyl-4,5-diphenyl-1H-imidazoles with six different glycosyls were 
obtained in 48–55% yields from the multicomponent reaction of the corresponding C-glycosyl 
methylamines, formaldehyde, benzil, and ammonium acetate under catalysis with indium(III) 
chloride in methanol at ambient temperature.  Starting with C--D-glucopyranosyl or C--D-
galactopyranosyl methylamines, the procedure also was examined with phenylglyoxal or 
glyoxal instead of benzil, and the pertinent 1--D-glycopyranosylmethyl-4-phenyl-1H-
imidazole and -5-phenyl-1H-imidazole or 1--D-glycopyranosylmethyl-1H-imidazole 
derivatives were prepared and isolated.  Of four differently 4- and 5-substituted 1-(-D-
glucopyranosylmethyl)-1H-imidazoles, only the 5-phenyl derivative exhibited a weak 
inhibition of rabbit muscle glycogen phosphorylase b (IC50 = 125 μM).  
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1.  Introduction 
 
Imidazoles are important heterocycles occurring in natural compounds,1 antifungal drugs 2 
and many other artificial substances with a variety of other biological activities, applicable in 
medicinal chemistry and pharmacology,3,4,5,6 as well as in material science,7,8,9 catalysis 9,10,11 
or the preparation of ionic liquids.12  Numerous methods for the synthesis of imidazoles have 
been designed, starting from the first Debus 13 and Radzisewski 14 syntheses up to their latest 
convergent annulations,15,16 and several pertinent reviews have appeared.17,18,19,20  Recently, a 
photochemical one-pot three-component synthesis of tetrasubstituted imidazoles has 
appeared.21  The multicomponent Debus-Radzisewski imidazole synthesis is still attracting 
strong interest in view of improving and simplifying the procedure, including its 
catalysis.22,23,24,25,26,27  In particular, InCl3, due to its non-toxic nature, low heterophilicity and  
compatibility with both organic and aqueous media, has emerged as a prominent Lewis acid 
catalyst in organic synthesis, including multicomponent reactions at room temperature.28  As 
such, a one-pot, four component synthesis of 1,2,4,5-tetrasubstituted imidazoles catalyzed by 
InCl3·3H2O has been shown to work efficiently in methanol at room temperature with 1,2-
dicarbonyl compounds of the benzil type, primary amines, ammonium acetate and aromatic 
aldehydes.24  This contribution evaluates the convenience of using the published procedure for 
the synthesis of 1-glycosylmethylated imidazoles as a novel group of carbohydrate mimetics 
from stable sugar primary amines, formaldehyde, ammonium acetate and also from 1,2-
dicarbonyl compounds other than those of the benzil type. 
 
2. Results and discussion 
 
Optimized conditions for the four component one pot reaction concerning the reaction 
solvent and the amount of catalyst 24 were chosen for all the synthetic experiments here.  The 
starting C-glycosyl methylamines are available in three steps from the parent aldoses via 
nitromethane addition, followed by thermally induced eliminative anhydrization of the 
obtained 1-deoxy-1-nitroalditols,29,30 and final electron-transfer reduction of the resulting 
glycosyl nitromethanes.31,32,33  Stirring a methanolic solution of equimolar amounts of sugar 
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amine 1a, benzil (2, R1 = R2 = Ph), formaldehyde, and ammonium acetate, with addition of a 
0.1 molar equivalent of InCl3, at rt for 48 h, followed by purification of the reaction mixture 
by flash chromatography, afforded the expected 1,4,5-trisubstituted imidazole 5a in 50% yield 
(Table 1).  1,4,5-Trisubstituted imidazoles 5b–5f were prepared similarly, using the 
corresponding sugar amines 1b–1f, and were isolated in 48–55% yields.  In addition to these 
products and unreacted benzil, the reaction mixtures also contained some more polar 
compounds on TLC.  Apparently, formaldehyde and glycosyl methylamines as the most 
reactive species in the reaction mixture produced 1,3-oxazinane and/or 1,3,5-triazine side 
products, analogous to those produced from formaldehyde and simpler aminoalcohols.34,35,36  
This was supported by the detection of the [(-D-GlcpCH2NH2) + (CH2O) – H2O + H]+ and 
[2(-D-GlcpCH2NH2) + (CH2O) – 2H2O + 2Na]2+ ions with the respective m/z = 206.10235 
(found) vs. 206.10230 (calcd) and m/z = 228.08429 (found) vs. 228.08424 (calcd) in the 
HRMS spectrum of the normal multicomponent reaction mixture with benzil and -D-
GlcpCH2NH2 even after 7 days.  In addition, there was also the [M + H]+ ion of the non-
glycosylmethylated 4,5-diphenylimidazole at m/z = 221.10736 (found) vs. 221.10732 (calcd), 
which also contributed to the decreased yields of the expected 1-glycosylmethylated 
imidazoles.  Comparable yields of imidazoles, when formaldehyde or another aliphatic 
aldehyde was the reaction component, have also been reported in the pilot paper.24 
Further, phenylglyoxal (3, R1 = Ph, R2 = H, Table 1) instead of benzil, the same other 
reaction components and conditions as above were used in this multicomponent reaction with 
carbohydrate amines 1a and 1b.  In both cases, both possible 4-phenyl and 5-phenyl gluco 
derivatives 6a and 7a, and galacto derivatives 6b and 7b were isolated.  Less sterically 
hindered 1,4-disubstituted imidazoles 6a and 6b were the major products, significantly 
prevailing over 1,5-disubstituted imidazoles 7a and 7b. 
Finally, glyoxal (4, R1 = R2 = H, Table 1) as the simplest 1,2-dicarbonyl compound was 
examined in place of benzil in this InCl3 catalyzed multicomponent synthesis of imidazoles.  
Thus, again with carbohydrate amines 1a and 1b, the respective 1-glycosylmethyl-1H-
imidazoles 8a and 8b were isolated in 41% and 45% yields.  Moreover, among all the 
glycosylmethylated imidazoles obtained here, compounds 8a and 8b most closely mimic 
normal disaccharides and are promising candidates to modulate activity of sugar processing 
enzymes.  The other glycosylated imidazoles known from the literature contain glycosyl 
moieties linked directly to the nitrogen or carbon atoms of the imidazole ring and mimic 
nucleosides rather than disaccharides.23,37,38,39 
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Table 1.  InCl3 catalyzed one-pot preparation of 1-glycosylmethylated imidazoles from C-glycosylmethylamines 
(1), formaldehyde, ammonium acetate, and benzil (2, R1 = R2 = Ph) or phenylglyoxal (3, R1 = Ph, R2 = H) or 
glyoxal (4, R1 = R2 = H) in methanol. 
58
product, yield (%)a
7ac (12%)
1'
3
1' 2' 
2'
4
3'
5
1
4'
5
8
2
5'
1
6'
2
3
9
4
7'
5d, 48%
10
6
11
7 8
6
7
9
8
10
8b (45%)
11
6bd (37%)
12
7
13
9
14
11
15
10
16
7be (12%)
3'
6
4'
5'
1
6'
2
5
7'
17
3
4
5a, 50%
  CH2O (1.0 equiv.)
NH4OAc (1.0 equiv.)
  InCl3 (0.1 equiv.)
1'
MeOH (4 mL)
    rt, 48 h
8a (41%)
1'
1 (1.0 mmol) 24 (1.0 mmol)
2'
2'
3'
3'
4'
4'
5'
5'
6'
6'
5f, 49%
7' 1'
1'
2'
2'
3'
4'
5'
6'
5e, 52%
3'
4'
5'
6'
7'
5c, 48%5b, 55%
6ab (34%)
 
a
 isolated yield.  b major product, in addition to the minor 7a.  c minor product, in addition to the major 6a.  d 
major product, in addition to the minor 7b.  e minor product, in addition to the major 6b. 
 
The structures of all 1-glycosylmethylated imidazoles were proved by their characteristic 
1H- and 13C-NMR spectra.  The chemical shift of the only hydrogen atom of the 1,4,5-
trisubstituted ring of imidazoles 5a–5e was observed at H-2 = 7.93  0.06, essentially at the 
same values as those observed for the 1,5-disubstituted ring of imidazoles 7a and 7b; H-2 = 
7.95 and 7.92, respectively.  On the other side, the chemical shifts of the same hydrogen atom 
of the 1,4-disubstituted ring of imidazoles 6a and 6b were recorded at the respective values of H-2 = 7.74 and 7.72, which are almost identical with those observed at H-2 = 7.69 and 7.64 
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for the respective 1-monosubstituted imidazoles 8a and 8b.  The apparent reason for the 
similar behaviour of the first two and the second two groups of imidazoles is cross-
conjugation.  While the (C-2)=(N-3) double bond in imidazoles 5a–5f, 7a and 7b is normally 
conjugated via the (C-4)=(C-5) double bond with their 5-phenyl group, at the same time it is 
only cross-conjugated with their 4-phenyl group in imidazoles 6a and 6b or without any 
interaction with no substituent in position 4 of imidazoles 8a and 8b.   
The distinction of the mono-phenylated imidazoles was done using classic 1H NMR NOE 
experiments as well and the space spin interaction between the sugar CH2N and phenyl CH 
protons was observed for imidazoles 7a and 7b with their 5-phenyl substitution only.  The 
values of the sugar vicinal proton-proton coupling constants proved that the configurations of 
the 1-glycosylmethyl moieties on the imidazole ring remained unchanged.  Similarly as for 
the signals of imidazole ring protons, the 13C chemical shifts of the individual imidazole ring 
carbon atoms were also found in narrow intervals, as, e.g., for the most populated series of  
1,4,5-trisubstituted imidazoles 5a–5f at C-2 = 138.15  0.29, C-4 = 136.96  0.35 and C-5 = 
129.01  0.30. 
The mechanism of the multicomponent synthesis of trisubstituted and tetrasubstituted 
imidazoles catalyzed by InCl3 has been proposed in two different respective versions.24  
However, the plausible mechanism of this multicomponent synthesis of imidazoles should be 
universal and encompassing all its peculiarities.  Therefore, the specification of the 
mechanism postulated here was first examined for the multicomponent reaction with 
phenylglyoxal (Scheme 1).  Indeed, the most nucleophilic secondary amino group of the 
intermediary adduct of C-glycosyl methylamine and ammonia to formaldehyde, preferentially 
should attack the most activated, aldehydic carbonyl of phenylglyoxal, leaving the remaining 
two counter reaction centres to close the next intermediate, imidazolidine ring.  The 
subsequent aromatization acompanied with 3,4- and 2,5-eliminations of two molecules of 
water stabilizes the reaction product, the structure of which is in accordance with the observed 
prevalence of the 1,4-disubstituted imidazoles 6a and 6b over 1,5-disubstituted imidazoles 7a 
and 7b. 
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R = -D-Glcp or -D-Galp
-
-
 
Scheme 1.  Plausible reaction pathway of the InCl3 catalyzed multicomponent synthesis of imidazoles with 
glycosylmethylamines, formaldehyde, ammonia and phenylglyoxal favouring the major 4-phenyl derivative over 
the 5-phenyl isomer. 
 
The results obtained in this study also allowed postulating the general addition-elimination 
mechanism of the multicomponent synthesis of imidazoles (Scheme 2).  Thus, the mechanism 
proposed here is plausible for the synthesis of unsubstituted up to tetrasubstituted imidazoles.   
 
R1, R2, R3, R4 = H or alkyl or aryl or arylalkyl
 
Scheme 2.  General addition-elimination mechanism of the InCl3 catalyzed multicomponent synthesis of 
imidazoles. 
 
Imidazoles 5a–8a, each of them containing both -D-glucopyranosyl and aromatic 
moieties, linked together by the methylene group, were tested for inhibition of rabbit muscle 
glycogen phosphorylase (RMGP) b.  Compounds 5a, 6a, and 8a did not inhibit the enzyme up 
to 625 µM concentration, while 7a showed weak inhibition characterized by an IC50 = 125 
µM value (calculated Ki = 68 μM).  Taking into account previous observations and structure-
activity relationships of RMGP b inhibitors,40,41,42 it is thought that the presence of the 
tetrahedral centre between the sugar and the aglycon may be responsible for the weak effect.  
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This moiety may lend the molecules high flexibility resulting in considerable loss of entropy 
upon binding. 
 
3. Conclusion 
 
In summary, this study has extended a one pot, multicomponent synthesis of aromatically 
trisubstituted and tetrasubstituted imidazoles catalyzed by InCl3 to the preparation of 1-
glycosylmethylated imidazoles as a novel group of carbohydrate mimetics.  The largely non-
aromatic character of the reaction components results in moderate yields of the target 
compounds, which may be on account of the competitive, non-aromatic side products, as 
indicated by the HRMS analysis of reaction mixtures. 
 
4.  Experimental 
 
4.1.  General information 
 
Melting points were measured on a Kofler stage.  Optical rotations were measured with a 
Jasco P2000 polarimeter at 20 °C.  High resolution mass determination was performed by 
ESI-MS on a Thermo Scientific Orbitrap Exactive instrument operating in positive mode.  1H- 
and 13C-NMR spectra were recorded at 295 K  on VNMRS 400 MHz Varian spectrometer 
equipped with 5 mm 1H–19 F/15 N–31P PFG AutoX DB NB probe head and on VNMRS 
600MHz Varian spectrometer equipped with HCN 13C enhanced salt tolerant cold probe.  
Chemical shifts are referenced to either CD3OD (δ 3.31 for 1H, δ 47.57 for 13C) or (CD3)2SO 
(δ 2.50 for 1H, δ 39.97 for 13C).  Full spectral assignment was done using the COSY, NOESY, 
HSQC, HMBC and H2BC NMR experiments.  Fourier-transform infra red (FTIR) spectra 
were measured with Thermo Fisher Scientific Nicolet 6700 spectrometer equipped with 
DTGS detector and Omnic 8.0 software.  The spectra were collected in the middle region 
from 4,000 to 400 cm-1 at a resolution of 4 cm-1, the number of scans was 128. Diamond 
Smart Orbit ATR accessory was applied for measurement in solid state.  TLC was run on 
Merck 60 F254 silica gel precoated aluminium plates; visualisation was effected by briefly 
immersing the plates into 10% ethanolic sulfuric acid and charring them with a hot air gun, or 
alternatively, by developing the plates with alkaline silver nitrate.  Flash chromatography was 
performed using Acros silica gel (37–75 m) and the S1 solvent mixture EtOAcn-
BuOHMeOHH2O 18:9:7:3 (v/v).  Additional flash chromatographic purification of product 
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imidazoles was done with the S2 solvent mixture PhMeMeOH 2:1 (v/v) for the benzil-based 
imidazoles and with the S3 solvent mixture EtOAc MeOH 1:1 (v/v) for the phenylglyoxal 
and glyoxal-based imidazoles.   
 
4.2.  Enzyme assay  
 
Glycogen phosphorylase b was prepared from rabbit skeletal muscle according to the 
method of Fischer and Krebs,43 using dithiothreitol instead of L-cysteine, and recrystallized at 
least three times before use with a specific activity of 55 U/mg protein. Kinetic experiments 
were performed in the direction of glycogen synthesis as described previously.44 Kinetic data 
for the inhibition of rabbit skeletal muscle glycogen phosphorylase were collected using 4 
mM of -D-glucose-1-phosphate 1% w/v of glycogen and 1 mM AMP, and various 
concentrations of inhibitor. Inhibitor was dissolved in DMSO and diluted in the assay buffer 
(final concentrations between 6.25 and 625 M) (50 mM triethanolamine, 100 mM KCl, 1 
mM EDTA and 1 mM dithiothreitol) so that the DMSO concentration in the assay should be 
lower than 1%. IC50 values, when possible, were determined using the previous conditions 
and the Ki was calculated using the BotDB IC50-to-Ki converter.45  
 
4.3. General procedure for synthesis of 1-glycosylmethyl-4,5-diphenyl-1H-imidazoles  
 
A mixture of starting C-glycosyl methylamine 31,32,33 [1 mmol, 193 mg of -D-
glucopyranosylmethylamine (1a) or -D-galactopyranosylmethylamine (1b) or -D-
mannopyranosylmethylamine (1c) or -D-galactofuranosylmethylamine (1d) or 163 mg of -
D-arabinopyranosylmethylamine (1e) or -D-xylopyranosylmethylamine (1f)], benzil (2, 210 
mg, 1 mmol), ammonium acetate (77 mg, 1 mmol), paraformaldehyde (30 mg) and InCl3 (22 
mg, 0.1 mmol) in methanol (4 mL) was stirred at rt for 48 h.  A white turbid matter (ca 10%), 
not containing the product imidazole [Rf 0.5 (S1)] was removed by paper filtration and the 
filtrate was concentrated at reduced pressure.  The evaporation residue was fractionated by 
flash chromatography first with eluant S1 and then S2. 
1-(2,6-Anhydro-1-deoxy-D-glycero-D-gulo-heptitol-1-yl)-4,5-diphenylimidazole (1--D-
glucopyranosyl-4,5-diphenylimidazole, 5a).  Yield 0.20 g (50%); mp 208–209 C; []D20 –
40.0 (c 1.0, MeOH); max(diamond anvil) 3235, 3061, 2866, 1660, 1595, 1444, 1070 cm-1; H 
(400 MHz, CD3OD) 7.99 (s, 1H, H-2), 7.41–7.46 (m, 3H, H-14–16), 7.28–7.36 (m, 4H, H-7, 
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H-11, H-13, H-17), 7.08–7.17 (m, 3H, H-8–10), 4.27 (dd, J1’a,1’b 14.6, J1’a,2’ 1.7 Hz, 1H, H-
1’a), 3.89 (dd, J1’b,2’ 8.3 Hz, 1H, H-1’b), 3.81 (dd, J7’a,7’b 11.9, J6’,7’a 2.3 Hz, 1H, H-7’a), 3.66 
(dd, J6’,7’b 5.2 Hz, 1H, H-7’b), 3.31–3.37 (m, 1H, H-2’), 3.23–3.31 (m, 2H, H-4’, H-5’), 3.19 
(ddd, J5’,6’ 9.5 Hz, 1H, H-6’), 3.00–3.06 (m, 1H, H-3’); C (100.6 MHz, CD3OD) 138.25 (C-
2), 136.82 (C-4), 134.10 (C-6), 131.07 (C-13, C-17), 130.01 (C-12), 128.87 (C-5), 128.62 (C-
14, C-16), 128.45 (C-15), 127.65 (C-8, C-10), 126.64 (C-7, C-11), 126.11 (C-9), 80.05 (C-6’), 
78.66 (C-2’), 78.04 (C-4’), 71.60 (C-3’), 70.02 (C-5’), 61.22 (C-7’), 46.21 (C-1’); HRMS 
(ESI): MH+, found 397.1756, C22H24N2O5H+ requires 397.1758. 
1-(2,6-Anhydro-7-deoxy-L-glycero-L-galacto-heptitol-7-yl)-4,5-diphenylimidazole (1--
D-galactopyranosyl-4,5-diphenylimidazole, 5b).  Yield 0.22 g (55%); mp 203–204 C; []D20  
–38.0 (c 1.0, MeOH); max(diamond anvil) 3340, 3059, 2858, 1603, 1504, 1441, 1090  cm-1; H (600 MHz, CD3OD) 7.99 (s, 1H, H-2), 7.40–7.46 (m, 3H, H-14–16), 7.30–7.36 (m, 4H, H-
7, H-11, H-13, H-17), 7.09–7.17 (m, 3H, H-8–10), 4.29 (dd, J7’a,7’b 14.6, J6’,7’a 1.8 Hz, 1H, H-
7’a), 3.93 (dd, J6’,7’b 8.5 Hz, 1H, H-7’b), 3.87 (d, J2’,3’, J3’,4’ 1.4 Hz, 1H, H-3’), 3.73 (dd, J1’a,1’b 
11.3, J1’a, 2’ 6.6 Hz, 1H, H-1’a), 3.70 (dd, J1’b, 2’ 5.5 Hz, 1H, H-1’b), 3.43–3.47 (m, 1H, H-2’), 
3.38–3.43 (m, 2H, H-5’, H-4’), 3.31–3.36 (m, 1H, H-6’); C (150.8 MHz, CD3OD) 138.08 (C-
2), 136.67 (C-4), 133.99 (C-6), 131.04 (C-13, C-17), 129.92 (C-12), 128.97  (C-5), 128.60 (C-
14, C-16), 128.44 (C-15), 127.65 (C-8, C-10), 126.62 (C-7, C-11), 126.13 (C-9), 79.22 (C-6’), 
78.60 (C-2’), 74.62 (C-4’), 69.17 (C-3’), 68.68 (C-5’), 61.13 (C-1’), 46.28 (C-7’); HRMS 
(ESI): MH+, found 397.1755, C22H24N2O5H+ requires 397.1758. 
1-(2,6-Anhydro-1-deoxy-D-glycero-D-galacto-heptitol-1-yl)-4,5-diphenylimidazole (1--
D-mannopyranosyl-4,5-diphenylimidazole, 5c).  Yield 0.19 g (48%); mp 234–236 C; []D20 –
22.0 (c 1.0, MeOH); max(diamond anvil) 3279, 3143, 2854, 1599, 1504, 1441, 1074 cm-1; H 
(600 MHz, CD3OD) 7.90 (s, 1H, H-2), 7.43–7.55 (m, 3H, H-14–16), 7.30–7.37 (m, 4H, H-7, 
H-11, H-13, H-17), 7.10–7.17 (m, 3H, H-8–10), 4.14 (dd, J1’a,1’b 14.7, J1’a, 2’ 8.5 Hz, 1H, H-
1’a), 4.01 (dd, J1’b, 2’ 4.2 Hz, 1H, H-1’b), 3.80 (dd, J7’a,7’b 11.8, J6’,7’a 2.3 Hz, 1H, H-7’a), 3.67 
(dd, J6’,7’b 5.5 Hz, 1H, H-7’b), 3.50–3.61 (m, 3H, H-2’, H-3’, H-5’), 3.34 (dd, J4’,5’ 9.5 Hz, 
J3’,4’ 3.4 Hz, 1H, H-4’), 3.08 (ddd, J5’,6’ 9.5 Hz, 1H, H-6’); C (150.8 MHz, CD3OD) 137.97 
(C-2), 137.31 (C-4), 134.02 (C-6), 130.85 (C-13, C-17), 130.19 (C-12), 129.31 (C-5), 128.84 
(C-14, C-16), 128.64 (C-15), 127.67 (C-8, C-10), 126.57 (C-7, C-11), 126.18 (C-9), 80.51 (C-
6’), 76.73 (C-2’), 74.64(C-4’), 69.68 (C-3’), 67.03 (C-5’), 61.37 (C-7’), 46.07 (C-1’); HRMS 
(ESI): MH+, found 397.1760, C22H24N2O5H+ requires 397.1758. 
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1-(3,6-Anhydro-7-deoxy-D-glycero-L-galacto-heptitol-7-yl)-4,5-diphenylimidazole (1--
D-galactofuranosyl-4,5-diphenylimidazole, 5d).  Yield 0.19 g (48%); mp 157–160 oC; []D20 
+2.0 (c 1.0, MeOH); max(diamond anvil) 3299, 3057, 2924, 1601, 1504, 1441, 1038 cm-1; H 
(600 MHz, CD3OD) 7.93 (s, 1H, H-2), 7.44–7.49 (m, 3H, H-14–16), 7.31–7.38 (m, 4H, H-7, 
H-11, H-13, H-17), 7.10–7.18 (m, 3H, H-8–10), 4.14 (dd, 1H, J6’,7’a 4.5, J7’a,7’b 14.4 Hz, H-
7’a), 4.06–4.12 (m, 2H, H-5’, H-7’b), 4.00–4.06 (m, 1H, H-6’), 3.83 (t, J2’,3’, J3’,4’ 2.7 Hz, 1H, 
H-3’), 3.72–3.79 (m, 2H, H-2’, H-4’), 3.62 (dd, 1H, J1’a,2’ 6.2, J1’a,1’b 11.0 Hz, H-1’a), 3.58 
(dd, 1H, J1’b,2’ 6.7 Hz, H-1’b); C (150.8 MHz, CD3OD) 137.86 (C-2), 137.21 (C-4), 133.99 
(C-6), 131.02 (C-12), 130.84 (C-13, C-17), 128.79 (C-14, C-16), 128.71 (C-5), 128.59 (C-15), 
127.68 (C-8, C-10), 126.60 (C-7, C-11), 126.19 (C-9), 85.32 (C-3’), 79.71 (C-6’), 78.87 (C-
5’), 76.63 (C-4’), 71.42 (C-2’), 62.79 (C-1’), 44.43 (C-7’); HRMS (ESI): MH+, found 
397.1758, C22H24N2O5H+ requires 397.1758. 
1-(2,6-Anhydro-1-deoxy-D-manno-hexitol-1-yl)-4,5-diphenylimidazole (1--D-
arabinopyranosyl-4,5-diphenylimidazole, 5e).  Yield 0.19 g (52%); mp 195–197 C; []D20 
+21.0 (c 1.0, MeOH); max(diamond anvil) 3371, 3051, 2897, 1601, 1502, 1439, 1065 cm-1; H (600 MHz, CD3OD) 7.87 (s, 1H, H-2), 7.42–7.47 (m, 3H, H-14–16), 7.31–7.36 (m, 4H, H-
7, H-11, H-13, H-17), 7.13– 7.18 (m, 2H, H-8, H-10), 7.10–7.13 (m, 1H, H-9), 4.31 (dd, 
J1’a,1’b 14.6, J1’a,2’ 1.6 Hz, 1H, H-1’a), 3.92 (dd, J1’b,2’ 8.9 Hz, 1H, H-1’b), 3.89 (dd, J6’a,6’b 
12.6, J5’,6’a 2.0 Hz, 1H, H-6’a), 3.80–3.82 (m, 1H, H-5’), 3.47 (dd, J5’,6’b 0.9 Hz, 1H, H-6’b), 
3.38–3.43 (m, 2H, H-3’, H-4’), 3.18–3.23 (m, 1H, H-2’); C (150.8 MHz, CD3OD) 138.05 (C-
2), 136.97 (C-4), 134.16 (C-6), 130.99 (C-13, C-17), 130.03 (C-12), 128.83 (C-5), 128.61 (C-
14, C-16), 128.43 (C-15), 127.64 (C-8, C-10), 126.66 (C-7, C-11), 126.10 (C-9), 79.43 (C-2’), 
73.97 (C-3’), 69.88 (C-6’), 69.26 (C-5’), 68.97 (C-4’), 46.39 (C-1’); HRMS (ESI): MH+, 
found 367.1651, C21H22N2O4H+ requires 367.1652. 
1-(2,6-Anhydro-1-deoxy-L-gluco-hexitol-6-yl)-4,5-diphenylimidazole (1--D-
xylopyranosyl-4,5-diphenylimidazole, 5f).  Yield 0.18 g (49%); mp 197–199 C; []D20 –26.0 
(c 1.0, DMSO); max(diamond anvil) 3354, 3115, 2848, 1601, 1504, 1414, 1093 cm-1; H (400 
MHz, (CD3)2SO) 7.75 (s, 1H, H-2), 7.45–7.51 (m, 3H, H-14–16), 7.31–7.38 (m, 4H, H-7, H-
11, H-13, H-17), 7.14–7.19 (m, 2H, H-8, H-10), 7.06–7.11 (m, 1H, H-9), 4.12 (dd, J6’a,6’b 
14.6, J5’,6’a  1.9 Hz, 1H, H-6’a), 3.75 (dd, J5’,6’b 9.0 Hz, 1H, H-6’b), 3.71 (dd, J1’a,1’b 11.0, J1’a,2’ 
5.3 Hz, 1H, H-1’a), 3.20–3.29 (m, 1H, H-2’), 3.16 (ddd, J4’,5’ 9.2, Hz, 1H, H-5’), 3.03 (dd, 
J2’,3’ 8.7 Hz, 1H, H-3’), 2.95 (dd, J1’b,2’ 10.8 Hz, 1H, H-1’b), 2.86 (dd, J3’,4’ 9.0 Hz, 1H, H-4’); C (100.6 MHz, (CD3)2SO) 138.43 (C-2), 136.76 (C-4), 135.41 (C-6), 131.45 (C-13, C-17), 
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130.93 (C-12), 129.36 (C-14, C-16), 129.08 (C-15), 128.94 (C-5), 128.43 (C-8, C-10), 126.34 
(C-7, C-9, C-11), 79.27 (C-5’), 78.36 (C-3’), 72.23 (C-4’), 70.07 (C-1’, C-2’), (46.82 (C-6’); 
HRMS (ESI): MH+, found 367.1650, C21H22N2O4H+ requires 367.1652.  
 
4.4.  General procedure for synthesis of 1-glycosylmethyl-4- and -5-phenyl-1H-
imidazoles 
 
A mixture of starting C-glycosyl methylamine [1 mmol, 193 mg of -D-
glucopyranosylmethylamine (1a) or -D-galactopyranosylmethylamine (1b)], phenylglyoxal 
hydrate (3, 152 mg, 1 mmol), ammonium acetate (77 mg, 1 mmol), paraformaldehyde (30 
mg) and InCl3 (22 mg, 0.1 mmol) in methanol (4 mL) was stirred at rt for 48 h.  Further work-
up was continued according to the above General methods.  In both cases, this procedure gave 
the major 4-phenyl derivatives [Rf 0.32 (S1)] and minor 5-phenyl derivatives [Rf 0.25 (S1)]. 
 1-(2,6-Anhydro-1-deoxy-D-glycero-D-gulo-heptitol-1-yl)-4-phenylimidazole (1--D-
glucopyranosyl-4-phenylimidazole, 6a).  Yield 0.11 g (34%); syrup; []D20 +11.0 (c 1.0, 
MeOH); max(diamond anvil) 3272, 2922, 2858, 1601, 1483, 1369, 1068 cm-1; H (400 MHz, 
CD3OD) 7.74 (d, J 1.3 Hz, 1H, H-2), 7.68–7.72 (m, 2H, H-7, H-11), 7.55 (d, J 1.3 Hz, 1H, H-
5), 7.30–7.36 (m, 2H, H-8, H-10), 7.18–7.23 (m, 1H, H-9), 4.40 (dd, J1’a,1’b 14.5, J1’a, 2’  2.1 
Hz, 1H, H-1’a), 4.21 (dd, J1’b, 2’ 6.1 Hz, 1H, H-1’b), 3.85 (dd, J7’a,7’b 12.0, J6’, 7’a 2.3 Hz, 1H, 
H-7’a), 3.64 (dd, J6’,7’b 5.8 Hz, 1H, H-7’b), 3,47 (ddd, J2’, 3’ 9.6 Hz, 1H, H-2’), 3.33–3.38 (m, 
1H, H-4’), 3.27 (ddd, J5’,6’ 9.6 Hz, 1H, H-6’), 3.19 (dd, J4’,5’ 8.8 Hz, 1H, H-5’), 2.99 (dd, J3’, 4’ 
9.1 Hz, 1H, H-3’); C (100.6 MHz, CD3OD) 140.81 (C-4), 138.66 (C-2), 133.88 (C-6), 128.14 
(C-8, C-10), 126.34 (C-9), 124.42 (C-7, C-11), 116.80 (C-5), 80.34 (C-6’), 78.35 (C-2’), 
78.21 (C-4’), 70.70 (C-3’), 70.25 (C-5’), 61.50 (C-7’), 47.57 (C-1’); HRMS (ESI): MH+, 
found 321.1443, C16H20N2O5H+ requires  321.1445. 
1-(2,6-Anhydro-7-deoxy-L-glycero-L-galacto-heptitol-7-yl)-4-phenylimidazole (1--D-
galactopyranosyl-4-phenylimidazole, 6b).   Yield 0.12 g (37%); syrup; []D20 –6.0 (c 1.0, 
MeOH); max(diamond anvil) 3275, 2921, 2858, 1600, 1481, 1371, 1049 cm-1; H (400 MHz, 
CD3OD) 7.72 (d, J 0.9 Hz, 1H, H-2), 7.66–7.70 (m, 2H, H-7, H-11), 7.55 (d, J 1.0, 1H, H-5), 
7.28–7.36 (m, 2H, H-8, H-10), 7.15–7.21 (m, 1H, H-9), 4.42 (dd, J7’a,7’b 14.7, J6’,7’a 1.1 Hz, 
1H, H-7’a), 4.13–4.19 (m, 1H, H-7’b), 3.85 (dd, J2’,3’ 3.0, J3’,4’ 0.8 Hz, 1H, H-3’), 3.73 (dd, 
J1’a,1’b 11.4, J1’a,2’ 6.9 Hz, 1H, H-1’a), 3.68 (dd, J1’ b,2’ 5.0 Hz, 1H, H-1’b), 3.38–3.51 (m, 4H, 
H-2’, H-4’–6’); C (100.6 MHz, CD3OD) 140.80 (C-4), 138.46 (C-2), 133.90 (C-6), 128.12 
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(C-8, C-10), 126.30 (C-9), 124.41 (C-7, C-11), 116.61 (C-5), 79.26 (C-6’), 78.81 (C-2’), 
74.83 (C-4’), 69.38 (C-3’), 68.13 (C-5’), 61.39 (C-1’), 48.12 (C-7’); HRMS (ESI): MH+, 
found 321.1443, C16H20N2O5H+ requires  321.1445.  
1-(2,6-Anhydro-1-deoxy-D-glycero-D-gulo-heptitol-1-yl)-5-phenylimidazole (1--D-
glucopyranosyl-5-phenylimidazole, 7a).  Yield 0.04 g (12%); syrup; []D20 –21.0 (c 1.0, 
MeOH); max(diamond anvil) 3255, 2920, 2854, 1585, 1483, 1373, 1072 cm-1; H (400 MHz, 
CD3OD) 7.95 (s, 1H, H-2), 7.41–7.48 (m, 4H, H-7, H-8, H-10, H-11), 7.36–7.41 (m, 1H, H-
9), 6.97 (s, 1H, H-4), 4.51 (dd, J1’a,1’b 14.7, J1’a, 2’ 1.8 Hz, 1H, H-1’a), 4.03 (dd, J1’b, 2’ 8.3Hz, 
1H, H-1’b), 3.80 (dd, J7’a,7’b 11.9, J6’,7’a 2.3 Hz, 1H, H-7’a), 3.65 (dd, J6’,7’b 5.2 Hz, 1H, H-
7’b), 3,40 (ddd, J2’, 3’ 9.9, 1H, H-2’), 3.26–3.36 (buried m, 2H, H-4’, H-5’), 3.15–3.20 (m, 1H, 
H-6’), 3.03–3.09 (m, 1H, H-3’); NOE contacts: H-1’a, 7 (11), H-1’a, 8 (10); C (100.6 MHz, 
CD3OD) 139.38 (C-2), 133.66 (C-5), 129.41 (C-6), 129.00 (C-7, C-11), 128.37 (C-8, C-10), 
127.81 (C-9), 125.59 (C-4), 80.05 (C-6’), 78.86 (C-2’), 78.07 (C-4’), 71.61 (C-3’), 70.04 (C-
5’), 61.23 (C-7’), 46.28 (C-1’); HRMS (ESI): MH+, found 321.1443, C16H20N2O5H+ requires  
321.1445.  
1-(2,6-Anhydro-7-deoxy-L-glycero-L-galacto-heptitol-7-yl)-5-phenylimidazole (1--D-
galactopyranosyl-5-phenylimidazole, 7b).  Yield 0.04 g (12%); syrup; []D20 –29.0 (c 1.0, 
MeOH); max(diamond anvil) 3262, 2918, 2858, 1562, 1483, 1404, 1051 cm-1; H (400 MHz, 
CD3OD) 7.92 (s, 1H, H-2), 7.32–7.48 (m, 5H, H-7–11), 6.96 (s, 1H, H-4), 4.52 (dd, J7’a,7’b 
14.6, J6’,7’a 1.5 Hz, 1H, H-7’a), 4.04 (dd, J6’,7’b 8.4 Hz, 1H, H-7’b), 3.86–3.90 (dd, 1H, H-3’), 
3.65–3.72 (m, 2H, H-1’a, H-1’b), 3.33–3.51 (m, 4H, H-2’, H-4’–6’); NOE contacts: H-7’a, 7 
(11), H-7’a, 8 (10); C (100.6 MHz, CD3OD) 139.23 (C-2), 133.59 (C-5), 129.40 (C-6), 
128.98 (C-7, C-11), 128.35 (C-8, C-10), 127.78 (C-9), 125.61 (C-4), 79.48 (C-6’), 78.57 (C-
2’), 74.64 (C-4’), 69.17 (C-3’), 68.76 (C-5’), 61.07 (C-1’), 46.32 (C-7’); HRMS (ESI): MH+, 
found 321.1443, C16H20N2O5H+ requires  321.1445.  
 
4.5.  General procedure for synthesis of 1-glycosylmethyl-1H-imidazoles 
 
A mixture of starting C-glycosyl methylamine [1 mmol, 193 mg of -D-
glucopyranosylmethylamine (1a) or -D-galactopyranosylmethylamine (1b)], glyoxal trimer 
dihydrate (3, 70 mg, 1/3 mmol), ammonium acetate (77 mg, 1 mmol), paraformaldehyde (30 
mg) and InCl3 (22 mg, 0.1 mmol) in methanol (4 mL) was stirred at rt for 48 h. Further work-
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up was continued according to the above General methods. Both product imidazoles obtained 
by this procedure had Rf 0.16 (S1). 
1-(2,6-anhydro-1-deoxy-D-glycero-D-gulo-heptitol-1-yl)-imidazole (1--D-
glucopyranosylimidazole, 8a).  Yield 0.10 g (41%); syrup; []D20 +16.0 (c 1.0, MeOH); max(diamond anvil) 3261, 3120, 2895, 1582, 1514, 1372, 1074 cm-1; H (400 MHz, CD3OD) 
7.69 (s, 1H, H-2), 7.20 (s, 1H, H-5), 6.93 (s, 1H, H-4), 4.37 (dd, J1’a,1’b 14.5, J1’a,2 2.1 Hz, 1H, 
H-1’a), 4.19 (dd, J1’b, 2 6.1 Hz, 1H, H-1’b), 3.83 (dd, J7’a,7’b 12.0, J6’,7’a 2.2 Hz, 1H, H-7’a),  
3.63 (dd, J6’ ,7’b 5.6 Hz, 1H, H-7’b), 3.32–3.46 (m, 2H, H-2’, H-4’), 3.08–3.27 (m, 2H, H-5’, 
H-6’), 2.94 (dd, J2’,3’ 9.2, J3’,4’ 9.4 Hz, 1H, H-3’); C (100.6 MHz, CD3OD) 138.09 (C-2), 
126.89 (C-4), 120.67 (C-5), 80.31 (C-6’), 78.38 (C-2’), 78.17 (C-4’), 70.65 (C-3’), 70.20 (C-
5’), 61.47 (C-7’), 47.36 (C-1’); HRMS (ESI): MH+, found 245.1130, C10H16N2O5H+ requires  
245.1132.  
1-(2,6-Anhydro-7-deoxy-L-glycero-L-galacto-heptitol-7-yl)-imidazole (1--D-
galactopyranosylimidazole, 8b).  Yield 0.11 g (45%); syrup; []D20 –12.0 (c 1.0, MeOH); max(diamond anvil) 3244, 3120, 2890, 1579, 1514, 1373, 1049 cm-1; H (400 MHz, CD3OD) 
7.64 (s, 1H, H-2), 7.10 (s, 1H, H-5), 6.86 (s, 1H, H-4), 4.32 (dd, J7’a,7’b 14.4, J6’,7’a 1.2 Hz, 1H, 
H-7’a), 4.05 (dd, J6’,7’b 6.7 Hz, 1H, H-7’b), 3.77 (dd, J2’,3’ 3.1, J3’,4’ 0.6 Hz, 1H, H-3’), 3.62 
(dd, J1’a,1’b 11.4, J1’a,2’ 6.8 Hz, 1H, H-1’a), 3.58 (dd, J1’ b,2’ 5.3 Hz, 1H, H-1’b), 3.34–3.39 (m, 
2H, H-2’, H-4’), 3.26–3.32 (m, 2H, H-5’, H-6’); C (100.6 MHz, CD3OD) 137.75 (C-2), 
126.66 (C-4), 120.49 (C-5), 79.26 (C-6’), 78.73 (C-2’), 74.77 (C-4’), 69.28 (C-3’), 68.13 (C-
5’), 61.26 (C-1’), 47.96 (C-7’); HRMS (ESI): MH+, found 245.1124, C10H16N2O5H+ requires  
245.1132.  
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Table(s)
Table 1.  InCl3 catalyzed one-pot preparation of 1-glycosylmethylated imidazoles from C-glycosylmethylamines 
(1), formaldehyde, ammonium acetate, and benzil (2, R1 = R2 = Ph) or phenylglyoxal (3, R1 = Ph, R2 = H) or 
glyoxal (4, R1 = R2 = H) in methanol. 
 
 
 
a
 isolated yield.  b major product, in addition to the minor 7a.  c minor product, in addition to the major 6a.  d 
major product, in addition to the minor 7b.  e minor product, in addition to the major 6b. 
 
Table(s)
R = -D-Glcp or -D-Galp
-
-
 
Figure(s)
Scheme 1.  Plausible reaction pathway of the InCl3 catalyzed multicomponent synthesis of imidazoles with 
glycosylmethylamines, formaldehyde, ammonia and phenylglyoxal favouring the major 4-phenyl derivative over 
the 5-phenyl isomer. 
Figure(s)
R1, R2, R3, R4 = H or alkyl or aryl or arylalkyl
  
Figure(s)
Scheme 2.  General addition-elimination mechanism of the InCl3 catalyzed multicomponent synthesis of 
imidazoles. 
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